反应详情

To a solution of 4-(2-ethylphenyl)-N-(4-methoxybenzyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide (400 mg, 0.77 mmol) in DCM (50 mL) was added TFA (2.0 mL) at 0° C. The reaction mixture was stirred at ambient temperature for 2 h. After completion, the reaction mixture was quenched with saturated aqueous sodium bicarbonate solution (20 mL) and extracted with ethyl acetate (2×50 mL). The combined organic layer was dried over sodium sulfate and concentrated under reduced pressure to obtain the crude product which was purified by prep HPLC purification to obtain 4-(2-ethylphenyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide (176 mg, 56.9%) as a white solid. MS (ESI, positive ion) m/z; 402.3 (M+1). 1H NMR (400 MHz, DMSO) δ 12.51 (s, 1H), 7.42-7.38 (m, 1H), 7.33 (dt, J=4.4, 2.0 Hz, 2H), 7.29-7.24 (m, 1H), 7.21 (d, J=4.6 Hz, 1H), 7.12 (d, J=2.0 Hz, 1H), 7.08 (dd, J=8.5, 2.0 Hz, 1H), 6.77 (d, J=4.4 Hz, 1H), 6.00 (d, J=8.5 Hz, 1H), 4.34 (dd, J=10.2, 3.1 Hz, 2H), 3.74 (dt, J=7.3, 3.8 Hz, 1H), 3.51 (d, J=12.5 Hz, 1H), 2.47-2.44 (m, 2H), 1.11 (t, J=7.5 Hz, 3H).

1. customAfter completion, the reaction mixture was quenched with saturated aqueous sodium bicarbonate solution (20 mL)
2. extractionextracted with ethyl acetate (2×50 mL)
3. dry with materialThe combined organic layer was dried over sodium sulfate
4. concentrationconcentrated under reduced pressure
5. customto obtain the crude product which
6. customwas purified by prep HPLC purification